| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 12 | / | 2023 | ||||||||
| Date of issue: | 2023-03-31 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Acquisition of treasury shares | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a reference to the public notice from 29 July 2020, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 24 March 2023 up to and including 30 March 2023. Krka acquired 4,066 treasury shares in the total value of EUR 431,418 on the Ljubljana Stock Exchange as follows: - on 24 March 2023: 810 shares at a VWAP of EUR 106.00, - on 27 March 2023: 1,024 shares at a VWAP of EUR 105.24, - on 28 March 2023: 500 shares at a VWAP of EUR 105.80, - on 29 March 2023 1,010 shares at a VWAP of EUR 106.87 and - on 30 March 2023: 722 shares at a VWAP of EUR 106.57. Price is calculated as volume weighted average price (VWAP). Ilirika d.d., Intercapital d.d, and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached. The total number of treasury shares prior to these transactions was 1,813,826 representing 5.531% of all shares issued. The total number of treasury shares after these transactions is 1,817,892 representing 5.543% of all shares issued. The notice will be published on the Company's website (www.krka.biz) from 31 March 2023 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Detailed report on acquisition of treasury shares.pdf | Detailed report on acquisition of treasury shares | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-03-31 | Jože Colarič | President of the Management Board and CEO | |||
Detailed report on acquisition of treasury shares.pdf
